XML 35 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Shareholders' Equity
12 Months Ended
Dec. 31, 2015
Shareholders' Equity  
Shareholders' Equity

Note 15—Shareholders' Equity

Bruker Corporation Stock Plan

        In February 2010, the Bruker BioSciences Corporation Amended and Restated 2000 Stock Option Plan, or the 2000 Plan, expired at the end of its scheduled ten-year term. On March 9, 2010, the Company's Board of Directors unanimously approved and adopted the Bruker Corporation 2010 Incentive Compensation Plan, or the 2010 Plan, and on May 14, 2010, the 2010 Plan was approved by the Company's stockholders. The 2010 Plan provides for the issuance of up to 8,000,000 shares of the Company's common stock. The Plan allows a committee of the Board of Directors (the "Committee") to grant incentive stock options, non-qualified stock options and restricted stock awards. The Committee has the authority to determine which employees will receive the awards, the amount of the awards and other terms and conditions of the award. Awards granted by the Committee typically vest over a period of three to five years.

        Stock option activity for the year ended December 31, 2015 was as follows:

                                                                                                                                                                                    

 

 

Shares
Subject to
Options

 

Weighted
Average
Option Price

 

Weighted
Average
Remaining
Contractual
Term (Yrs)

 

Aggregate
Intrinsic Value
(in millions) (b)

 

Outstanding at December 31, 2014

 

 

4,810,588

 

$

15.24

 

 

 

 

 

 

 

Granted

 

 

1,107,477

 

 

19.81

 

 

 

 

 

 

 

Exercised

 

 

(926,042

)

 

11.81

 

 

 

 

 

 

 

Forfeited

 

 

(354,744

)

 

19.17

 

 

 

 

 

 

 

​  

​  

Outstanding at December 31, 2015

 

 

4,637,279

 

$

16.72

 

 

6.5

 

$

35.0

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Exercisable at December 31, 2015

 

 

2,355,197

 

$

14.08

 

 

4.7

 

$

24.0

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Exercisable and expected to vest at

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2015 (a)

 

 

4,504,918

 

$

16.64

 

 

6.5

 

$

34.4

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  


 

 

 

(a)          

In addition to the options that are vested at December 31, 2015, the Company expects a portion of the unvested options to vest in the future. Options expected to vest in the future are determined by applying an estimated forfeiture rate to the options that are unvested as of December 31, 2015.

(b)          

The aggregate intrinsic value is based on the positive difference between the fair value of the Company's common stock price of $24.27 on December 31, 2015, or the date of exercises, as appropriate, and the exercise price of the underlying stock options.

        The weighted average fair values of options granted was $7.82, $10.81 and $10.37 per share for the years ended December 31, 2015, 2014 and 2013, respectively.

        The total intrinsic value of options exercised was $8.2 million, $10.0 million and $8.1 million for the years ended December 31, 2015, 2014 and 2013, respectively.

        Unrecognized pre-tax stock-based compensation expense of $16.7 million related to stock options awarded under the 2010 Plan is expected to be recognized over the weighted average remaining service period of 2.2 years for stock options outstanding at December 31, 2015.

        Restricted shares of the Company's common stock are periodically awarded to executive officers, directors and certain key employees of the Company, subject to service restrictions, which vest ratably over periods of four to five years. The restricted shares of common stock may not be sold or transferred during the restriction period. Stock-based compensation for restricted stock is recorded based on the stock price on the grant date and charged to expense ratably throughout the restriction period. The following table summarizes information about restricted stock activity during the year ended December 31, 2015:

                                                                                                                                                                                    

 

 

Shares
Subject to
Restriction

 

Weighted
Average Grant
Date Fair
Value

 

Outstanding at December 31, 2014

 

 

309,725

 

$

17.20

 

Granted

 

 

135,677

 

 

19.83

 

Vested

 

 

(56,395

)

 

17.02

 

Forfeited

 

 

(145,857

)

 

17.42

 

​  

​  

Outstanding at December 31, 2015

 

 

243,150

 

$

18.58

 

​  

​  

​  

​  

​  

​  

​  

​  

        The total fair value of restricted stock vested was $1.0 million, $3.0 million and $1.4 million for the years ended December 31, 2015, 2014 and 2013, respectively.

        Unrecognized pre-tax stock-based compensation expense of $3.9 million related to restricted stock awarded under the 2010 Plan is expected to be recognized over the weighted average remaining service period of 2.8 years for awards outstanding at December 31, 2015.